PH13794A - Tetrahydropyranyl ether derivative of prostaglandins - Google Patents

Tetrahydropyranyl ether derivative of prostaglandins

Info

Publication number
PH13794A
PH13794A PH18199A PH18199A PH13794A PH 13794 A PH13794 A PH 13794A PH 18199 A PH18199 A PH 18199A PH 18199 A PH18199 A PH 18199A PH 13794 A PH13794 A PH 13794A
Authority
PH
Philippines
Prior art keywords
prostaglandins
ether derivative
tetrahydropyranyl ether
tetrahydropyranyl
derivative
Prior art date
Application number
PH18199A
Inventor
M Johnson
J Bindra
T Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH13794A publication Critical patent/PH13794A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
PH18199A 1972-11-08 1976-03-12 Tetrahydropyranyl ether derivative of prostaglandins PH13794A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
PH13794A true PH13794A (en) 1980-10-01

Family

ID=23178143

Family Applications (2)

Application Number Title Priority Date Filing Date
PH15198A PH15504A (en) 1972-11-08 1973-11-08 P-biphenyl esters of 15-substituted-omega-penta-norprostaglandins
PH18199A PH13794A (en) 1972-11-08 1976-03-12 Tetrahydropyranyl ether derivative of prostaglandins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PH15198A PH15504A (en) 1972-11-08 1973-11-08 P-biphenyl esters of 15-substituted-omega-penta-norprostaglandins

Country Status (24)

Country Link
JP (1) JPS5644068B2 (en)
AR (2) AR204816A1 (en)
AT (1) AT347607B (en)
BE (1) BE807047A (en)
CA (1) CA1027559A (en)
CH (1) CH601222A5 (en)
CS (1) CS188175B2 (en)
DD (2) DD111370A5 (en)
DE (2) DE2365999A1 (en)
ES (2) ES420326A1 (en)
FI (1) FI58116C (en)
FR (2) FR2205339B1 (en)
GB (1) GB1456511A (en)
HU (2) HU171945B (en)
IE (1) IE39686B1 (en)
IL (1) IL43553A (en)
IN (1) IN139905B (en)
NL (1) NL7315240A (en)
NO (2) NO145437C (en)
PH (2) PH15504A (en)
SE (2) SE420198B (en)
SU (2) SU538659A3 (en)
YU (2) YU287973A (en)
ZA (1) ZA738593B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361381A1 (en) * 1972-07-13 1978-03-10 Pfizer (15)-(Hetero) aryl prostaglandin analogues - with long-lasting prostaglandin-like activity
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (en) * 1976-08-27 1978-03-09 Pfizer C LOW 1 -P-BIPHENYLESTER OF OMEGA-PENTANORPROSTAGLANDINES
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
JPS5644068B2 (en) 1981-10-16
HU171945B (en) 1978-04-28
FI58116C (en) 1980-12-10
SU1021340A3 (en) 1983-05-30
PH15504A (en) 1983-02-03
NO146280C (en) 1982-09-01
GB1456511A (en) 1976-11-24
FR2275452B1 (en) 1977-12-16
AU6222573A (en) 1975-05-08
NO146280B (en) 1982-05-24
FI58116B (en) 1980-08-29
NL7315240A (en) 1974-05-10
IE39686L (en) 1974-05-08
ATA937173A (en) 1978-05-15
CS188175B2 (en) 1979-02-28
FR2275452A1 (en) 1976-01-16
IE39686B1 (en) 1978-12-06
BE807047A (en) 1974-05-08
JPS49100060A (en) 1974-09-20
FR2205339B1 (en) 1980-01-04
NO743588L (en) 1974-05-09
IN139905B (en) 1976-08-14
DD113211A5 (en) 1975-05-20
IL43553A (en) 1979-10-31
ES434687A1 (en) 1976-12-16
DE2355042A1 (en) 1974-05-22
AR202311A1 (en) 1975-05-30
NO145437C (en) 1982-03-24
CH601222A5 (en) 1978-06-30
NO145437B (en) 1981-12-14
YU264480A (en) 1983-04-27
SE420198B (en) 1981-09-21
YU287973A (en) 1982-02-25
IL43553A0 (en) 1974-03-14
FR2205339A1 (en) 1974-05-31
AT347607B (en) 1979-01-10
SU538659A3 (en) 1976-12-05
AR204816A1 (en) 1976-03-05
SE7704369L (en) 1977-04-15
CA1027559A (en) 1978-03-07
ES420326A1 (en) 1976-03-16
DE2365999A1 (en) 1977-05-12
ZA738593B (en) 1974-10-30
HU171818B (en) 1978-03-28
DD111370A5 (en) 1975-02-12

Similar Documents

Publication Publication Date Title
HK14279A (en) Prostaglandin analogues
PH13325A (en) Prostaglandin intermediates
GB1485946A (en) Method of producing prostaglandins
ZA714805B (en) Novel ether
YU36924B (en) Process for obtaining prostaglandins
PH13794A (en) Tetrahydropyranyl ether derivative of prostaglandins
ZA732244B (en) Prostaglandin analogs
GB1400936A (en) Microbiological reduction of 1o-11-unsaturated prostaglandins
ZA732352B (en) Prostaglandin analogs
AU469908B2 (en) Prostaglandin analogs
JPS5781457A (en) Manufacture of prostaglandin like compound
JPS5466677A (en) Manufacture of diglycydyl ether
MY7700075A (en) Difluoromethylene substituted prostaglandin derivatives
JPS51125033A (en) Preparation of ether compound
AU6322173A (en) Prostaglandin compositions
AU6034273A (en) Prostaglandin compounds
ZA728737B (en) Prostaglandin derivatives
AU457798B2 (en) 15-alkyl ethers of prostaglandins
ZA735902B (en) Use of prostaglandins for abortion
CA942755A (en) Intermediates for preparing prostaglandins
CA942756A (en) Intermediates for preparing prostaglandins
CA942759A (en) Intermediates for preparing prostaglandins
CA942758A (en) Intermediates for preparing prostaglandins
CA942760A (en) Intermediates for preparing prostaglandins
AU478835B2 (en) Use of prostaglandins for abortion